Picture8
28 - Chemistry today for Next Gen2

About Us

European Innovation and Manufacturing

We are committed to developing and manufacturing critical raw materials and reagents in Portugal for the global pharmaceutical and fine chemicals industries. By focusing on innovation and high-quality production processes, we contribute to the resilience and independence of supply chains worldwide.

R&D and Innovation

Small Molecules for Great Ideas

Commercial Applications

Science -Based Products Made in Europe

  • Innovation at Our Core
  • Strengthening Supply Chains
  • Supporting Pharma & Fine Chemicals
  • Committed to Sustainability
about-shape-2-1
Anceus Company

Why you should choose Us

Created with Fabric.js 5.2.4

Purpose

Our Purpose is to develop and manufacture in Portugal critical raw materials and reagents for the global pharmaceutical and fine chemical industries, adding value with innovative production processes and solutions, and contributing to the independence and resilience of supply chains.

join-shape-1-1

Mission

To develop manufacturing solutions and manufacture in Europe essential raw materials and reagents for the global pharmaceutical and fine chemical industries in a safe and sustainable manner.


join-shape-1-1

Vision

To be the business partner that solves supply chain problems through the development of innovative solutions for resilient, local, and sustainable manufacturing, utilizing advanced technologies.


join-shape-1-1

Culture

ANCEUS is a flexible and agile science-based company with high ethics and customer focus. We develop our teams, invest in technology and collaborate with the best experts in the fields we operate, to offer consistent high-quality products made with the best technologies to competitively support our customers.

join-shape-1-1

ANCEUS has been awarded the recognition of NOVA Spin-Off ®, joining a vibrant ecosystem where Academia and Innovative Companies work together in Chemistry, Healthcare, Nanotechnology, Biotechnology and Artificial Intelligence, among others.

With this recognition, ANCEUS gains access to:

- Exclusive and royalty-free licensing of the developed intellectual property, until the commercialization stage.
- Use of Lab space and state-of-art equipment of the Nova School of Science and Technology and Nova School of Medicine.
- Duly authorized time allocation for teachers and researchers who are promoters of the NOVA Spin-off ®, to support the development of the commercial project.